Health In Tech (HIT) Q3 2026 earnings review
Health In Tech cuts its sales plan as losses mount
Health In Tech, an online insurance marketplace for self-funded employer health plans, saw its revenue drop while bad-debt write-offs drove a steep loss. Third-quarter revenue fell 22%, and gross profit shrank 40% as third-party administration costs weighed on margins. A $5 million credit-loss charge across receivables and loans pushed the company to a $7 million net loss. New chief executive Sanjay Shrestha cut the full-year revenue plan to about $30 million, which by our math leaves fourth-quarter sales flat with the third quarter.
| Gross profit (like-for-like top-line read) | $3.1M -40.5% from a year ago |
|---|---|
| Revenue | $6.6M -22.4% from a year ago |
| Net loss per share | $(0.11) $0.01 profit a year ago |
| Full-year 2026 revenue outlook | Cut to ~$30M prior plan: $45–50M |
⚖️ Verdict: 🔴🔴 Very Bearish
The story got worse because management abandoned its second-half recovery plan and wrote off a large share of its balance sheet receivables. Even though the pipeline of quoted policies more than doubled, the company lowered its expected conversion rate to 3% to 7%, so year-to-date contracted revenue barely budged. On the positive side, the company launched its HitRix marketplace for large employers and signed the first client for its three-year rate program.
The question now is whether the carrier transition merely delayed new policies into 2027 or masked ongoing customer attrition. If the bottleneck was temporary, the 984-broker network and HitRix should convert quotes into active policies during the January renewal season; if clients are leaving, contracted revenue will stay flat. The business client count in the third-quarter filing and initial 2027 revenue targets will settle it.
🐂 Bull Case
HitRix Launches and Rate Program Signs First Client
Health In Tech relies on two new offerings to expand into larger employer groups, though long sales cycles carry execution risk. In September the company launched HitRix, an AI marketplace for large-group self-funded stop-loss insurance (coverage that caps an employer's health claim payouts). The tool offers "automated data ingestion, streamlining submissions across multiple carriers".
The company also signed the first employer client for its Three-Year Rate Stabilization Program, which locks in multi-year pricing predictability, and targets a full launch by year-end. Neither product contributed meaningful revenue in the third quarter, so commercial proof still lies ahead.
What to watch: fourth-quarter policy placements from HitRix during the January renewal season. A rise in bound policies would show that brokers are using the new marketplace for large accounts.
Broker Network Grows 16% as Carrier Switch Nears End
Health In Tech distributes its health plans through insurance brokers, third-party administrators (firms that process claims), and agencies. That network reached 984 distribution partners at the end of September, up 15.9% from a year ago and up 51 partners from the second quarter.
The company also stated that its transition to a new insurance carrier is now "substantially completed" after delaying policy start dates for two quarters. Completing the carrier switch removes the operational bottleneck that management blamed for this year's sales drop.
What to watch: whether the press release or filing for the fourth quarter names an A-rated carrier on the platform. Large brokerage houses require that rating before they will place employer groups.
🐻 Bear Case
Full-Year Revenue Plan Cut by 37%
For three quarters management maintained that its full-year revenue would reach $45 million to $50 million, arguing that onboarding a new insurance carrier only shifted revenue into the second half. This quarter the company cut that full-year plan to about $30 million, a 36.8% reduction from the middle of the prior range.
The company blamed the "delayed commencement of certain new policies resulting from the transition to a new carrier", which pushed sales into 2027. By our math, the new target leaves $6.6 million of revenue for the fourth quarter, down 12.3% from a year ago. Because policies earn revenue evenly over twelve months, fourth-quarter sales for January start dates cannot lift 2026 results.
What to watch: the initial 2027 revenue outlook when full-year results arrive. That number will test whether the delayed policies actually shifted into next year or disappeared.
Pipeline Grew While Conversion Rate Dropped
Chief executive Sanjay Shrestha said "reported financial performance has not yet fully reflected the potential of our platform" and pointed to $156.4 million in pipeline revenue (the full-term value of policies being quoted or bound). However, the numbers behind that pipeline show that quotes are barely turning into active contracts.
- Non-contracted pipeline: $153.8 million as of October 30, up from $64.4 million in July
- Expected conversion rate: 3% to 7%, down from 15% to 40% in the second quarter
- Contracted revenue (policies active at any point in 2026): $32.7 million for the first nine months, up $0.4 million from the first half by our math
- Platform Placed Plan Value (total plan dollars flowing through the platform): $91.8 million year to date, up $7.8 million in the third quarter by our math
"Our immediate priority is to improve quote-to-bind conversion, translate marketplace activity into placed policies and recognized revenue, and strengthen overall financial performance." Because the expected conversion rate fell so far, a non-contracted pipeline more than twice as large yields only $7.7 million at the middle of the range, by our math. Meanwhile, the release did not update the business client count, which fell from 942 to 396 over the prior year.
What to watch: the business client count in the third-quarter filing. Another drop would confirm that customer attrition, not just slow quote conversion, is shrinking the book.
Credit Losses Wipe Out Receivables and Loans
Collection delays from the prior carrier and side receivables turned into income-statement losses this quarter. Health In Tech recorded a $5.3 million provision for credit losses (charges for uncollectible money owed to the company), which equaled 81.0% of third-quarter revenue.
- Other receivables credit loss: $2.6 million in the quarter, bringing the balance-sheet allowance to $3.5 million
- Accounts receivable bad debt expense: $1.9 million in the quarter, creating a $1.9 million allowance
- Loans receivable credit loss: $0.9 million, writing the $0.8 million loan balance down to zero
Management excludes the $3.4 million of losses on loans and other receivables from Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization, and one-offs), but keeps the $1.9 million accounts receivable write-down inside it. Even without those write-downs, higher sales and marketing spending (up 20.0 percentage points of revenue) pushed Adjusted EBITDA to a $3.9 million loss.
What to watch: cash collections on the remaining $3.2 million of net accounts receivable and $1.7 million of net other receivables in the fourth quarter. Further write-downs would show that the remaining balances are also impaired.
Convertible Debt Keeps Cash Afloat While Operations Burn
Since January 2026, Health In Tech acts as the principal on pre-designed health plans, which puts third-party administrator fees into cost of revenue (the direct cost of delivering services). That shift cut gross margin by 14.1 percentage points from a year ago to 46.5%, and gross profit fell 40.5% to $3.1 million.
Because gross profit no longer covers overhead, operations burned $7.3 million of cash over the first nine months, and software development took another $1.8 million. The company ended September with $10.1 million in cash only because it raised $6.4 million in equity earlier this year and $6.7 million from convertible notes (debt that can convert into stock) in the third quarter, paying $0.8 million in financing fees.
What to watch: how the company settles its upcoming convertible note installments in the fourth quarter. Paying in stock rather than cash would increase share dilution.
👓 Other Themes
New Chief Executive Starts Operational Review
Health In Tech appointed former board member Sanjay Shrestha as chief executive on October 20, while founder Tim Johnson became executive chairman and Tim Cortes joined as an independent director. Shrestha "initiated a comprehensive review of our commercial operations, organizational capabilities, cost structure, and capital allocation priorities" and plans to share details with full-year results, including potential acquisitions.
💲 Other KPIs
Revenues from fees (SMR, the company's division that charges monthly per-employee administrative fees) fell 16.1% from a year ago and 12.2% from the second quarter. This stream makes up 90.4% of total revenue. Despite recording plan-administration fees on a gross basis this year, lower policy volumes pulled the line down for a second straight quarter.
Revenues from underwriting modeling (ICE, technology fees calculated as a percentage of insurance premiums) dropped 54.5% from a year ago and 50.3% from the second quarter. The decline has steepened for three quarters as carrier transition delays held back new stop-loss policy underwriting.
Weighted average diluted shares rose 7.3% from a year ago and 10.0% from the first quarter. On the balance sheet, issued Class A common shares reached 53.6 million at September 30, up 16.5% from December 2025 following the March private equity placement and equity award settlements.
🔮 Guidance
Cut. Management lowered the full-year revenue plan by $17.5 million from the middle of its prior range, which now points to a 10.0% decline from 2025. By our math, that leaves $6.6 million of revenue for the fourth quarter, flat with the third quarter and down 12.3% from a year ago. The company blamed extended underwriting timelines during its carrier transition, which shifted new policy revenue into 2027.
❓ Key Questions
What was the business client count on September 30?
Business clients fell from 942 to 396 over the four quarters ended June 2026, and the third-quarter press release did not include the number. Investors need the figure from the quarterly filing to see if customer attrition has stopped.
Why did expected pipeline conversion drop to 3–7%?
In the second quarter management applied a 15% to 40% conversion rate to its pipeline, but this quarter it cited 3% to 7%. What changed in quoting quality or broker behavior to cause that drop?
Which counterparties defaulted on the written-down receivables and loans?
The company wrote off $5.3 million across accounts receivable, other receivables, and its $0.86 million loan receivable. Were these losses tied to the legacy stop-loss carrier and the Kang Youle Limited loan?
Has an A-rated stop-loss carrier joined the platform?
In August management hoped to add an A-rated carrier within 30 days to unlock large brokerage firms. The release says the carrier transition is substantially complete but does not mention the carrier's rating.